Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-10

Clinical Trial Update: Identifying Changes in Food Behaviors Associated With Beginning GLP-1 Medication

View source ↗

Summary

A Penn State University-sponsored clinical trial is investigating how starting GLP-1 medications for weight loss influences food behaviors, including food selec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GLP-1 receptor agonist (unspecified)

Snippet

Sponsor: Penn State University | Conditions: Weight Loss, Food Selection | Status: RECRUITING